| Trial ID: | L6095 |
| Source ID: | NCT00846716
|
| Associated Drug: |
Pioglitazone Add On To Su Or Biguanide
|
| Title: |
Shiga Progression of Diabetes, Nephropathy and Retinopathy
|
| Acronym: |
SHIP-DINER
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone add on to SU or biguanide|DRUG: SU or Biguanide
|
| Outcome Measures: |
Primary: Onset and progression of diabetic nephropathy, 2 years | Secondary: Progression of diabetes mellitus change from the baseline in HbA1c change from the baseline in albumine/creatinine ratio change from the baseline in cystatin C onset and progression of diabetic retinopathy safety assessment, 2 years
|
| Sponsor/Collaborators: |
Sponsor: Shiga University | Collaborators: Kanazawa Medical University|Nagahama Red Cross Hospital|Nagahama City Hospital|Kohka Public Hospital|Second Okamoto General Hospital|Omihachiman COmmunity Medical Center|Yasu Hospital|Toyosato Hospital|Ako City Hospital|Horide Clinic|Kawabata Clinic|Seta Clinic|Shiga Clinic|Osaka University|NTT West Osaka Hospital|Hyogo prefectural Amagasaki Hospital|Tomita Clinic|Sawada Clinic|Social Insurance Shiga Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-03
|
| Completion Date: |
2011-11
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-19
|
| Locations: |
Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00846716
|
